Janus Henderson Group PLC Axsome Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 14,000 shares of AXSM stock, worth $1.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,000

Previous 14,000 -0.0%

Holding current value

$1.86 Million

Previous $1.63 Million 10.48%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $12,355 - $15,134	-188 Reduced 1.33%	14,000 $1.13 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $69 - $97	1 Added 0.01%	14,188 $1.13 Million
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $1,607 - $2,341	-28 Reduced 0.2%	14,187 $1.13 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $831 - $986	12 Added 0.08%	14,215 $993,000
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $1,226 - $1,897	-21 Reduced 0.15%	14,203 $1.02 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $540,457 - $694,200	9,256 Added 186.31%	14,224 $877,000
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $198,421 - $396,048	4,968 New	4,968 $383,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $179,146 - $347,014	4,968 New	4,968 $222,000
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $107,786 - $231,786	-4,958 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $117,504 - $205,211	4,958 New	4,958 $205,000
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $10.7 Million - $15.6 Million	-211,581 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $13.3 Million - $19.3 Million	-237,072 Reduced 52.84%	211,581 $12 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $4.39 Million - $5.73 Million	-66,230 Reduced 12.86%	448,653 $36.6 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $428,355 - $538,045	-6,268 Reduced 1.2%	514,883 $36.7 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $26 Million - $51.4 Million	521,151 New	521,151 $42.9 Million

Others Institutions Holding AXSM

# of Institutions

410

Shares Held

37.4M

Call Options Held

510K

Put Options Held

541K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.71B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Axsome Therapeutics, Inc. Transaction History